Cereno Scientific to participate in upcoming investor conferences
Cereno Scientific (XSAT: CRNO B) today announced that the company will participate at multiple upcoming investor conferences where CEO Sten R. Sörensen will present progress of clinical and preclinical development programs and future outlook.ABG Sundal Collier Life Science Summit (virtual) Date/time: May 19, 2022, 8.30-9.00 CET Presenter: CEO Sten R. Sörensen Registration to attend: Please contact your ABGSC contact person Redeye Growth Day 2022 (hybrid) Date/time: June 2, 2022, 8.40-9.00 CET Presenter: Presentation by CEO Sten R. Sörensen (virtual), Q&A by CMO Björn